EvidNet
EvidNet is a South Korea-based healthcare data analytics company that operates the FeederNet RWD/RWE platform, standardizing hospital EMR data into OHDSI/OMOP Common Data Model format to serve pharmaceutical companies, biotech firms, hospitals, and government health authorities with multi-center research and real-world evidence services.
- Company typePrivate
- Founded2017
- HeadquartersSeoul, South Korea
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What EvidNet does
EvidNet is a Seoul-headquartered healthcare data analytics company founded in 2017 that operates the FeederNet RWD/RWE platform, converting heterogeneous hospital electronic medical record (EMR) data into the international OHDSI/OMOP Common Data Model (CDM) format to enable multi-center clinical research without centralizing raw patient data. The platform connects 46-50+ Korean hospitals covering 57M+ standardized patient records and 300B+ data points, integrated with national claims databases (HIRA, NHIS), genomic, medical imaging, and patient-generated health data. The company's full product suite, marketed under the EVIX brand, includes EVIX-ONE (multi-center collaborative research), EVIX-MART (ETL and data integration), EVIX-INSIGHT/INSIGHT PRO (RWE disease statistics across the top 500 diseases in Korea), EVIX-FIND (clinical trial site/patient identification with 10-business-day turnaround), EVIX-RESEARCH (retrospective cohort studies), EVIX-PV/PMS (MFDS-compliant postmarketing surveillance), EVIX-EXPLO (no-code GUI statistical analysis), and the more recent subscription products EVIX-Dynamics and EVIX-Tracker (pharma prescription analytics). A consumer-facing app, MediPangPang, integrates personal health records across hospitals.
EvidNet's revenue is generated through a mix of subscription platform access, on-demand contract research studies (pilot and full studies), data extension/ETL services, and clinical site identification projects, with primary customers being pharmaceutical and biotech companies (retrospective studies, postmarketing surveillance, prescription analytics), hospital and academic medical center researchers (multi-center studies), and government health authorities (CDM standardization projects). The company holds ISO/IEC 27001:2013 certification (the first Korean medical data platform to do so) and has built an international profile through OHDSI community participation, including a COVID-19 study-a-thon and a Gates Foundation-funded COVID-19 data standardization project. The platform also supports federated learning for AI model training across distributed hospital data.
Cumulatively funded at approximately $26.1M USD (Series A of ~$11.5M, Shinhan Financial Group investment of ~$7.7M, and combined Hanmi/SK seed of ~$6.9M), EvidNet initiated IPO preparation in March 2023, appointed a new President (Jeon Seung, formerly 20 years at IQVIA) in November 2022 to drive commercialization, and continues expanding its hospital network, international data partnerships, and product surface.
EvidNet firmographics
Firmographics- Name
- EvidNet
- Legal name
- evidnet Inc.
- Website
- https://evidnet.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- EvidNet is a South Korea-based healthcare data analytics company that operates the FeederNet RWD/RWE platform, standardizing hospital EMR data into OHDSI/OMOP Common Data Model format to serve pharmaceutical companies, biotech firms, hospitals, and government health authorities with multi-center research and real-world evidence services.
- Ownership category
- akta.pro rank
EvidNet industry classification
Industry- Product category
- Real-World Evidence Platform
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industry
- Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)
Keywords
Where EvidNet is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
EvidNet business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Subscription Platform Services: Annual/monthly subscription tiers for EVIX platform tools (EVIX-ONE, EVIX-INSIGHT, EVIX-EXPLO, EVIX-DYNAMICS, EVIX-TRACKER). Web-based dashboard enabling multi-access. Revenue from pharma, biotech, and healthcare company subscriptions for ongoing data analytics access.
- On-Demand Contract Research: Per-study fees for EVIX-RESEARCH (retrospective cohort studies, comparative effectiveness/safety studies) and EVIX-PV/PMS (postmarketing surveillance). Pilot studies (1-3 months) and full studies (longer duration) with manuscript preparation support for scientific publications. Study lead time varies by complexity and hospital administrative procedures.
- Data Extension and ETL Services: EVIX-MART on-demand ETL and data quality management services converting and expanding data from various sources including national claims data, national statistics, medical imaging, genomic data, and patient-generated health data.
- Clinical Site Identification: EVIX-FIND fast-track aggregated patient count query service enabling pharma companies to quickly identify eligible clinical trial sites and patient numbers based on eligibility criteria. Results provided within 10 business days.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Web-based subscription tiers (EVIX-DYNAMICS, EVIX-TRACKER) |
| Subscription | Multi-year contract | EVIX-RESEARCH pilot study and full study classifications |
| Subscription | Annual | EVIX-INSIGHT PRO in-depth RWE subscription |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
EvidNet product offering
Product offeringCore offering
EvidNet operates the FeederNet RWD/RWE platform that standardizes hospital EMR data into a Common Data Model (CDM) and delivers a suite of analytics products (EVIX-ONE, EVIX-MART, EVIX-INSIGHT, EVIX-FIND, EVIX-RESEARCH, EVIX-PV/PMS, EVIX-EXPLO, EVIX-Dynamics, EVIX-Tracker) for multi-center clinical research, retrospective studies, clinical trial site identification, pharmacovigilance, and prescription trend analytics. The platform also includes the MediPangPang/EVIX-HEALTH consumer app for personal health record management.
Product overview
EvidNet is a healthcare data analytics company operating the FeederNet® RWD/RWE platform, which is a comprehensive ecosystem of interconnected products serving clinical researchers, pharmaceutical/ healthcare companies, and patients. The core platform is built around data standardization via CDM (Common Data Model) and provides specialized modules: EVIX-ONE™ for multicenter collaborative research, EVIX-MART™ for data integration/ETL services, EVIX-INSIGHT™/EVIX-INSIGHT PRO™ for disease analytics and RWE insights, EVIX-FIND™ for clinical trial site identification, EVIX-RESEARCH™ for retrospective studies, EVIX-PV/PMS™ for pharmacovigilance, and EVIX-EXPLO™ for no-code statistical analysis. The portfolio also includes subscription analytics tools EVIX-Dynamics™ and EVIX-Tracker™ for pharmaceutical prescription analysis, plus consumer-facing MediPangPang/EVIX-HEALTH™ app for personal health record management.
Differentiator
Problem solved
Functional benefit
Brands
- EVIX-ONE™: Multicenter collaborative research platform for remote study design and execution
- EVIX-MART™
- EVIX-FIND™
- EVIX-RESEARCH™
- EVIX-PV/PMS™
- EVIX-INSIGHT™
- EVIX-INSIGHT PRO™
- EVIX-EXPLO™
- EVIX-Dynamics™
- EVIX-Tracker™
- 메디팡팡 (Medipangpang)
- 피더넷 (FeederNet®)
- Evix-Health™
Products and services
- EVIX-ONE Multicenter collaborative research platform enabling remote study design and execution across partner hospitals' data networks for clinical researchers and pharmaceutical companies. Supports cohort definitions, comparative effectiveness studies, and AI modeling through integrated ATLAS interface.
- EVIX-MART On-demand ETL and data quality management service converting, expanding, and integrating data from EMR systems, national claims data (HIRA/NHIS), medical imaging, genomic data, and patient-generated health data.
- EVIX-INSIGHT Real-world evidence platform providing disease statistics on top 500 diseases in Korea, including frequently prescribed drugs, procedures, and lab tests based on HIRA and hospital EMR data.
- EVIX-INSIGHT PRO Advanced RWE platform providing in-depth cohort-specific insights for specific research interests, offering richer information on specific cohorts compared to the base EVIX-INSIGHT.
- EVIX-FIND Fast-track aggregated patient count query service for clinical trial site selection, providing eligibility criteria matching and hospital contact points within 10 business days for pharmaceutical companies.
- EVIX-RESEARCH On-demand retrospective research service supporting comparative effectiveness studies, safety studies, lab test analysis, adverse drug reaction prediction, and regulatory submission documentation for pharmaceutical companies.
- EVIX-PV/PMS Postmarketing surveillance service using RWD/RWE platform for drug adverse event detection and effectiveness/safety monitoring in compliance with MFDS database study guidelines.
- EVIX-EXPLO GUI-based exploratory data analysis tool enabling no-code statistical analysis and visualization for researchers without coding expertise, supporting CDM format and various public datasets.
- EVIX-Dynamics Subscription-based pharmaceutical prescription statistics analysis product providing prescription trend analytics, including hospital inpatient prescription statistics not available in external pharmacy data. Web dashboard-based with multi-access capability.
- EVIX-Tracker Subscription-based pharmaceutical prescription statistics tracking tool providing prescription pattern analysis with web dashboard for multi-access and detailed data analysis capabilities.
- MediPangPang / EVIX-HEALTH (메디팡팡) Consumer-facing medical mydata platform app integrating and managing personal health records from multiple hospitals, supporting telemedicine services. Operated by the Medipangpang CIC subsidiary established in January 2022.
Quantifiable outcome
- Clinical research that previously took months to years can now be conducted in hours using the FeederNet distributed analysis network
- +3 more outcomes
Companies that use EvidNet
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
EvidNet technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
EvidNet partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered strategic, minor, major and core.
- Medisafe Korea (메디세이프)strategicMOU signed in July 2024 for joint RMP (Risk Management Plan) business using RWD/RWE. Partnership combines EvidNet's RWD/RWE platform with Medisafe's drug safety management expertise to launch innovative services in 'database study-based post-market safety management'. Medisafe's CEO Im Min-jung leads drug safety operations with 20+ years of multinational pharma experience.
- MTG (엠티이지)strategicMOU signed in February 2024 with MTG, a medical imaging AI solutions company. Partnership aims to: (1) provide analysis services combining clinical data with medical imaging analysis data, and (2) pursue mutual cooperation for overseas business expansion. MTG's unstructured medical video data analysis technology combined with EvidNet's structured data creates synergies in healthcare diagnostics.
- Seoul National University Graduate School AI Major (서울대학교 대학원 협동과정 인공지능전공)strategicMOU signed in November 2023 for AI research cooperation in the medical field. Partnership aims to strengthen research cooperation in medical AI technology development and big data. Joint efforts to advance medical AI technology through academic-industry collaboration.
- DreamCiiA (드림씨아이에스)minorMOU signed in February 2023 for joint clinical and RWE research business. Partnership to pursue collaborative research projects in clinical studies and real-world evidence using EvidNet's RWD/RWE platform capabilities.
- National Health Insurance Service Ilsan Hospital (국민건강보험 일산병원)strategicMOU signed in September-October 2022 for CDM data-based research cooperation enhancement. Partnership established clinical data infrastructure through CDM linkage between the hospital and EvidNet's data network, enabling collaborative research projects.
- Korea Roche Diagnostics (한국로슈진단)strategicPartnership through EvidNet serving as 'data partner' for Korea Roche Diagnostics' NebiFi TumorBoard platform at Kangwon National University Hospital. EvidNet handles technical integration between the hospital's EMR and Roche's clinical decision support platform. Demonstrates EvidNet's role as a data infrastructure provider for major global healthcare companies.
- Korea University Anam Hospital (고려대학교 안암병원)minorMOU for medical big data utilization signed in June 2021. Partnership to utilize the hospital's clinical data for multi-center collaborative research through EvidNet's standardized data platform.
- Soonchunhyang University Seoul Hospital (순천향대서울병원)minorData-based research cooperation agreement signed in May 2021. Partnership enables the hospital to participate in multi-center research projects through EvidNet's data network and standardization technology.
- Daegu Catholic University Hospital (대구가톨릭대병원)minor'Data Research Innovation Project' agreement signed in May 2021. Partnership to advance the hospital's data research capabilities through EvidNet's standardized data infrastructure and CDM conversion technology.
- NewFlight (뉴플라이트)minorMOU signed in August 2020 for AI-based drug repurposing research. Partnership aimed at accelerating drug discovery through AI analysis using EvidNet's clinical big data combined with NewFlight's bio company builder capabilities. Targeting early clinical entry and faster commercialization through drug repositioning.
- Utilitex (유틸렉스)minorMOU signed in June 2020 for immune-oncology drug development. Utilitex received NSCLC, CRC, HCC biomarkers and related data from EvidNet to support clinical planning for its immune-oncology pipeline using AI-powered analysis of real-world patient data.
- Kangwon National University Hospital (강원대학교병원)minorCDM-based global clinical trial support service agreement signed in December 2019. Kangwon National University Hospital provides quality medical data through CDM linkage while EvidNet provides data analysis technology. Partnership aims to attract diverse global clinical trials and activate the international research ecosystem.
- Miso Information Technology (미소정보기술)strategicStrategic MOU signed in August 2019 for CDM-based Clinical Data Warehouse (CDW) development and service provision. Partnership leverages Miso's CDW technology (for integrating clinical and research data, EMR text and structured data) with EvidNet's CDM standardization. Pilot service targeted for January 2020.
- IQVIA Korea (아이큐비아)majorMOU signed in June 2019 for cooperation in RWD/RWE (Real World Data/Evidence) fields. IQVIA is a global life sciences analytics and tech solutions company. The partnership aims to elevate EvidNet's CDM data quality to regulatory-grade standards and activate the CDM-based research ecosystem in Korea through joint academic events and research collaboration.
- Korea 41+ Hospitals (CDM Network)coreDistributed bio-health big data project involving 41+ hospitals and 34,000+ hospital beds in a CDM-based data standardization initiative. Industry-Academia-Research collaboration for converting hospital medical information to Common Data Model (CDM) format. Project led by the Ministry of Trade, Industry and Energy and coordinated with companies including SK, ViewN, and StandardM.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
EvidNet competitors and assessment
Company assessmentDirect peers
- TriNetX: TriNetX operates a global federated health research network enabling clinical trial site identification and real-world evidence generation across hospital networks. Most direct peer to EvidNet's FeederNet platform, with comparable OMOP/CDM-based federated research model, though TriNetX has significantly broader global hospital coverage while EvidNet is Korea-focused.
- Flatiron Health: US-based oncology-focused real-world evidence company (acquired by Roche) that aggregates de-identified patient data from oncology clinics and partners with pharma for RWE generation. Direct peer in RWE platform business with similar pharma/biotech customer base, though focused on oncology rather than full therapeutic area coverage.
- Tempus Labs: AI-powered precision medicine company combining clinical and molecular data for RWE generation and pharma R&D support. Peer in the RWD/RWE space with similar technology approach of integrating multi-modal data (clinical, genomic, imaging) for pharma and clinical research use cases.
- Aetion: Real-world evidence analytics platform used by pharma, payers, and regulators for drug development, market access, and safety studies. Direct peer in RWE analytics for pharma R&D and regulatory submissions, with comparable focus on regulatory-grade evidence for FDA/HSA submissions.
Broad incumbents
- IQVIA: Global leader in real-world evidence, clinical research, and life sciences analytics. Both a strategic partner of EvidNet (MOU since 2019) and the dominant global competitor in RWE/RWD platforms. EvidNet's new President Jeon Seung came from IQVIA, and the two collaborate in Korean RWE ecosystem development.
- Health Catalyst: Healthcare data and analytics platform serving health systems and life sciences companies with data warehousing, analytics, and population health insights. Comparable in healthcare data analytics but broader scope, with primary focus on health system customers rather than pharma R&D.
- Datavant: Health data connectivity platform that enables de-identified data exchange across healthcare organizations for research and analytics. Comparable in healthcare data infrastructure with similar privacy-preserving data linkage capabilities, though focused on data connectivity layer rather than analytics applications.
- Medidata Solutions (Dassault Systèmes): Clinical trial technology platform providing EDC, CTMS, eCOA, and analytics for life sciences R&D. Comparable in clinical trial informatics and pharma R&D technology stack, though Medidata focuses on trial execution while EvidNet focuses on real-world evidence generation from clinical practice data.
- Veradigm (formerly Allscripts): Healthcare technology company providing EHR systems, practice management, and data analytics to hospitals and ambulatory providers. Comparable in healthcare data infrastructure with access to large-scale clinical data, with analytics offerings that overlap EvidNet's hospital data analytics capabilities.
Regional players
- M3 (M3 Inc.): Japanese healthcare technology and data company providing physician panels, clinical research, and RWE services across Asia. Regional peer in Asia-Pacific healthcare data with similar business model of aggregating healthcare professional and patient data for pharma R&D use cases.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
EvidNet social profiles
Digital presenceEvidNet compliance and trust
Trust signalCompliance1 record
EvidNet financial estimates
Financial estimateRevenue estimate
Valuation estimate
EvidNet leadership team
Management profileNumber of profiles
Profiles3 records
EvidNet subsidiaries and ownership
Company hierarchySubsidiaries1 record
EvidNet funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EvidNet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EvidNet
What does EvidNet do?
EvidNet operates the FeederNet RWD/RWE platform that standardizes hospital EMR data into a Common Data Model (CDM) and delivers a suite of analytics products (EVIX-ONE, EVIX-MART, EVIX-INSIGHT, EVIX-FIND, EVIX-RESEARCH, EVIX-PV/PMS, EVIX-EXPLO, EVIX-Dynamics, EVIX-Tracker) for multi-center clinical research, retrospective studies, clinical trial site identification, pharmacovigilance, and prescription trend analytics. The platform also includes the MediPangPang/EVIX-HEALTH consumer app for personal health record management.
Is EvidNet a public or private company?
EvidNet is a private company. It is classified as venture growth investor backed and is currently operating.
When was EvidNet founded?
EvidNet was founded in 2017. It employs 51 to 100 people.
Where is EvidNet based?
EvidNet is headquartered in Seoul, South Korea, in the Asia region.
How does EvidNet make money?
Four revenue lines are on record. Subscription Platform Services are the primary driver. The others are on-Demand Contract Research, data Extension and ETL Services and clinical Site Identification.
Who are EvidNet's main competitors?
Direct peers on record are TriNetX, Flatiron Health, Tempus Labs and Aetion. Broad incumbents are IQVIA, Health Catalyst, Datavant, Medidata Solutions (Dassault Systèmes) and Veradigm (formerly Allscripts). M3 (M3 Inc.) is listed as a regional player.
Does EvidNet have an API?
No public API is recorded for EvidNet.
What industry is EvidNet in?
EvidNet's product category is Real-World Evidence Platform. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up). Its NAICS code is 5182 and its SIC code is 8000.